Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Revvity (0KHE) Share Price & Analysis

0 Followers

0KHE Stock Chart & Stats

$159.11-$1.52(0.77%)
At close: 4:30 PM GMT
$120$140$160Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$156.68 - $165.82
52-Week Range
$80.00 - $172.00
Previous Close
$157.90
Volume
N/A
Average Volume (3M)
942
Market Cap
$17.75B
Enterprise Value
$19.12B
Total Cash (Recent Filing)
$592.80M
Total Debt (Recent Filing)
$2.77B
Price to Earnings (P/E)
70.4
Beta
0.87
Next Earnings
Feb 04, 2027 (Est.)
EPS Estimate
1.61
Next Dividend Ex-Date
Jan 22, 2027
Dividend Yield
0.18%

Bulls Say, Bears Say

Bulls Say

Software Recurring Growth

Strong Signals software growth and renewals add a recurring, workflow-embedded revenue stream that can improve customer retention and revenue visibility. New AI, logistics, and informatics products broaden the platform opportunity and may support durable expansion as adoption develops across laboratory customers.

Broad Growth And Margin Expansion

Growth across life sciences and diagnostics, combined with meaningful operating leverage, indicates that Revvity's transformation is improving the earnings profile. Raised growth, margin, and EPS guidance provides evidence that stronger demand and efficiency gains can persist beyond a single product or quarter.

Cash Generation And Deleveraging

High free-cash-flow conversion gives Revvity internal funding for product development, portfolio actions, and debt reduction. Fixed-rate debt, a long maturity profile, and declining leverage also strengthen financial resilience, allowing management to pursue strategic investments without relying heavily on near-term refinancing.

Bears Say

Compressed Profitability

Although earnings have recovered from the 2023 loss, profitability remains well below prior peaks and shareholder returns are modest. The lower earnings base means Revvity must sustain operational improvements and revenue growth to rebuild returns, while persistent margin compression could limit internally generated growth capacity.

Geographic Reproductive-health Pressure

Reproductive-health weakness in APAC, particularly amid challenging Chinese birth-rate conditions, creates a structural drag on part of the diagnostics portfolio. Continued pressure can reduce regional growth and make the company's overall performance more dependent on life sciences momentum and other geographies.

China Immunodiagnostics Divestiture

The pending divestiture addresses a business that is currently weighing on diagnostics margins, but it also changes Revvity's geographic and portfolio mix. Until closing, the unit remains a reported headwind, while the post-sale company will need replacement growth to offset the business being removed.

Revvity News

0KHE FAQ

What was Revvity’s price range in the past 12 months?
Revvity lowest share price was $80.00 and its highest was $172.00 in the past 12 months.
What is Revvity’s market cap?
Revvity’s market cap is $17.75B.
When is Revvity’s upcoming earnings report date?
Revvity’s next earnings report is estimated for Feb 04, 2027 (not yet confirmed), which is in 84 days.
How were Revvity’s earnings last quarter?
Revvity released its earnings results on Nov 03, 2026. The company reported $1.38 earnings per share for the quarter, beating the consensus estimate of $1.297 by $0.083.
Is Revvity overvalued?
According to Wall Street analysts Revvity’s price is currently Undervalued.
Does Revvity pay dividends?
Revvity pays a quarterly dividend of $0.07 which represents an annual dividend yield of 0.18%. See more information on Revvity dividends here
What is Revvity’s EPS estimate?
Revvity’s EPS estimate is 1.61.
How many shares outstanding does Revvity have?
Revvity has 111,586,400 shares outstanding.
What happened to Revvity’s price movement after its last earnings report?
Revvity reported an EPS of $1.38 in its last earnings report, beating expectations of $1.297. Following the earnings report the stock price went up 9.963%.
Which hedge fund is a major shareholder of Revvity?
Hedge funds hold Revvity shares: the largest hedge-fund position in Revvity is 463,271,010 shares, and hedge funds decreased their holdings by 328.0K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology